These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 12849008

  • 21. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies.
    Chen X, Fu S, Chen F, Chen H, Chen Z.
    Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843
    [Abstract] [Full Text] [Related]

  • 22. IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.
    Kessler SM, Laggai S, Barghash A, Schultheiss CS, Lederer E, Artl M, Helms V, Haybaeck J, Kiemer AK.
    Cell Death Dis; 2015 Oct 01; 6(10):e1894. PubMed ID: 26426686
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
    Dong ZZ, Yao DF, Yao DB, Wu XH, Wu W, Qiu LW, Jiang DR, Zhu JH, Meng XY.
    World J Gastroenterol; 2005 Aug 14; 11(30):4655-60. PubMed ID: 16094705
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling.
    Kessler SM, Pokorny J, Zimmer V, Laggai S, Lammert F, Bohle RM, Kiemer AK.
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb 15; 304(4):G328-36. PubMed ID: 23257922
    [Abstract] [Full Text] [Related]

  • 27. Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.
    Li L, Chen SH, Yu CH, Li YM, Wang SQ.
    J Proteome Res; 2008 Feb 15; 7(2):611-20. PubMed ID: 18161940
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
    Liu M, Varela-Ramirez A, Li J, Dai L, Aguilera RJ, Zhang JY.
    Oncol Rep; 2015 May 15; 33(5):2245-52. PubMed ID: 25779011
    [Abstract] [Full Text] [Related]

  • 30. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH, Park BC.
    Gan To Kagaku Ryoho; 1995 Aug 15; 22 Suppl 3():292-307. PubMed ID: 7661600
    [Abstract] [Full Text] [Related]

  • 31. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
    Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX.
    Oncol Rep; 2014 Oct 15; 32(4):1550-6. PubMed ID: 25109745
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.
    Qian J, Yao D, Dong Z, Wu W, Qiu L, Yao N, Li S, Bian Y, Wang Z, Shi G.
    Am J Clin Pathol; 2010 Nov 15; 134(5):799-806. PubMed ID: 20959664
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
    Shimizu T, Inoue K, Hachiya H, Shibuya N, Aoki T, Kubota K.
    J Hepatobiliary Pancreat Sci; 2016 Aug 15; 23(8):467-71. PubMed ID: 27246794
    [Abstract] [Full Text] [Related]

  • 36. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.
    Liu X, Ye H, Li L, Li W, Zhang Y, Zhang JY.
    J Immunol Res; 2014 Aug 15; 2014():326593. PubMed ID: 24872956
    [Abstract] [Full Text] [Related]

  • 37. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
    Himoto T, Kuriyama S, Zhang JY, Chan EK, Kimura Y, Masaki T, Uchida N, Nishioka M, Tan EM.
    Int J Oncol; 2005 Oct 15; 27(4):1079-85. PubMed ID: 16142326
    [Abstract] [Full Text] [Related]

  • 38. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC.
    Heo CK, Woo MK, Yu DY, Lee JY, Yoo JS, Yoo HS, Ko JH, Kim JM, Choi JY, Kim IG, Paik SG, Cho EW.
    Int J Oncol; 2010 Jun 15; 36(6):1453-9. PubMed ID: 20428769
    [Abstract] [Full Text] [Related]

  • 39. p62 Expression in primary carcinomas of the digestive system.
    Qian HL, Peng XX, Chen SH, Ye HM, Qiu JH.
    World J Gastroenterol; 2005 Mar 28; 11(12):1788-92. PubMed ID: 15793865
    [Abstract] [Full Text] [Related]

  • 40. Processing body autoantibodies reconsidered.
    Bloch DB, Gulick T, Bloch KD, Yang WH.
    RNA; 2006 May 28; 12(5):707-9. PubMed ID: 16641511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.